Investing News The FDA has given Sanofi’s hemophilia A drug BLA the Priority Review Status. August 30, 2022
Investing News Trxade Prime Plus Program by TRxADE Health Introduces Next-Day Delivery Options August 30, 2022
Investing News Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner August 29, 2022
Trading Tips Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine? August 26, 2022
Search
